Compare TGL & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGL | BRTX |
|---|---|---|
| Founded | 2020 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Managed Health Care |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 3.1M |
| IPO Year | 2022 | 2015 |
| Metric | TGL | BRTX |
|---|---|---|
| Price | $3.57 | $1.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 19.9K |
| Earning Date | 12-01-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.53 | N/A |
| EPS | ★ 16.03 | N/A |
| Revenue | ★ $5,169,784.00 | $81,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $383.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 121.83 | N/A |
| 52 Week Low | $0.14 | $0.14 |
| 52 Week High | $587.80 | $28.99 |
| Indicator | TGL | BRTX |
|---|---|---|
| Relative Strength Index (RSI) | 81.19 | 37.30 |
| Support Level | $2.59 | $1.32 |
| Resistance Level | $4.27 | $2.93 |
| Average True Range (ATR) | 0.12 | 0.12 |
| MACD | 0.42 | 0.03 |
| Stochastic Oscillator | 75.82 | 9.88 |
Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, a digital rewards and lifestyle platform based in Malaysia that uses artificial intelligence to offer personalized shopping deals, discounts, and rebates, and targets consumers by providing personalized deals based on their purchase history, location, and preferences. The company has two reportable segments: the ZCITY platform, which generates the maximum revenue, and Customized software development service.
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.